Modified eProtocol-insulin for critically ill patients and application software
10.3760/cma.j.cn121430-20201203-00742
- VernacularTitle:改良急危重症患者电子化胰岛素调节方案及应用软件
- Author:
Qiong GU
1
;
Lihui ZHANG
;
Weifeng YING
;
Weizhong CAO
;
Huijie YU
Author Information
1. 浙江中医药大学，杭州 310053
- Keywords:
eProtocol-insulin;
Glycemic control;
Application Software
- From:
Chinese Critical Care Medicine
2021;33(12):1508-1510
- CountryChina
- Language:Chinese
-
Abstract:
Dysglycemia is independently associated with the mortality of critically ill patients. Therefore, the management of blood glucose plays an important role in comprehensive therapy. It is suggested that the same target value of blood glucose (7.8-10.0 mmol/L) should not be set for all critically ill patients. Instead, it should be individually set based on the causes of the patient's admission and the status of blood glucose before admission. For this reason, there is an urgent need for a convenient protocol and method to regulate the dosage of insulin. The first hospital of Jiaxing, collaborating with information engineers, developed a modified eProtocol-insulin for domestic population with mathematical modeling and developed an Application Software (APP), which is convenient for clinical use. This is the first eProtocol-insulin and smart device APP for critically ill patients in China.
